Form 4: Supernus Pharmaceuticals Director Frederick M. Hudson Sells Shares

Director Frederick M. Hudson sold 8,722 shares of Supernus Pharmaceuticals (SUPN) at an average price of $36.28 on November 8, 2024.

Summary

• On November 8, 2024, Frederick M. Hudson, a director of Supernus Pharmaceuticals, sold 8,722 shares of common stock.
• The shares were sold at a weighted average price of $36.28.
• Following the transaction, Hudson directly owns 28,395 shares of Supernus Pharmaceuticals.
• The sale was executed under transaction code 'S'.
• The reporting person has undertaken to provide full information regarding the number of shares sold at each separate price within the range of $36.25 to $36.31 upon request.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of a stock sale by a company director. The sale itself doesn't necessarily indicate a positive or negative outlook.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company insiders, allowing investors to monitor their actions and potentially gain insights into their perspectives on the company's value.

Stakeholder Impact

• The sale of shares by a director could be perceived differently by stakeholders.
• Some may see it as a lack of confidence in the company's future, while others may view it as a personal financial decision.

Key Dates